Late-onset hypogammaglobulinemia after rituximab therapy
Development and implementation into practice of biologic agents has dramatically changed the approaches to the treatment of many severe diseases. But in the light of experience of their use more and more attention is paid not only to their efficacy but also to side effects. One of such medications i...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ECO-vector
2019-12-01
|
| Series: | Kazanskij Medicinskij Žurnal |
| Subjects: | |
| Online Access: | https://kazanmedjournal.ru/kazanmedj/article/viewFile/11540/9008 |